Secobarbital Sodium for Injection
» Secobarbital Sodium for Injection is Secobarbital Sodium suitable for parenteral use. It contains not less than 90.0 percent and not more than 110.0 percent of the labeled amount of secobarbital sodium (C12H17N2NaO3).
Packaging and storage—
Preserve in Containers for Sterile Solids as described under Injections 
1
.
1.
') + '&img=../../images/v35300/cas-76-73-3.gif',600,500);)
Constituted solution—
At the time of use, it meets the requirements for Constituted Solutions under Injections 1.
1.
Bacterial endotoxins 85—
It contains not more than 0.9 USP Endotoxin Unit per mg of secobarbital sodium.
85—
It contains not more than 0.9 USP Endotoxin Unit per mg of secobarbital sodium.
Other requirements—
It conforms to the Definition, responds to the Identification tests, and meets the requirements for pH, Completeness of solution, Loss on drying, Heavy metals, and Assay under Secobarbital Sodium. It meets also the requirements for Sterility Tests 71, Uniformity of Dosage Units 905, and Labeling under Injections 1.
71, Uniformity of Dosage Units 905, and Labeling under Injections 1.
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
| Topic/Question | Contact | Expert Committee |
|---|---|---|
| Monograph | Hariram Ramanathan, M.S.
Associate Scientific Liaison 1-301-816-8313 |
(SM42010) Monographs - Small Molecules 4 |
| Reference Standards | RS Technical Services 1-301-816-8129 rstech@usp.org |
|
| 85 |
Radhakrishna S Tirumalai, Ph.D.
Principal Scientific Liaison 1-301-816-8339 |
(GCM2010) General Chapters - Microbiology |
USP35–NF30 Page 4620